Tanzania
Research Article
Cytotoxicity of Nutritional Supplement Galaxy@ against HepG2 Hepatocellular Carcinoma
Author(s): David B Jeffs, Alexander C Martin, Erick R Rosenvall, Tyson Fillmore, Katelyn E Barrett and Gary M BoothDavid B Jeffs, Alexander C Martin, Erick R Rosenvall, Tyson Fillmore, Katelyn E Barrett and Gary M Booth
Current treatment for hepatocellular carcinoma consists of chemotherapy and invasive tumor removal surgery. These forms of treatment have often been disappointing while new and natural methods to treat liver cancer may be preferred. We tested the cytotoxic effects of the fruit mixture Galaxy® against HepG2 hepatocellular carcinoma cells in vitro. Galaxy® was evaluated using three groups; thus, cytotoxicity bioassays were determined against: whole product (unfractionated), the supernatant, and the particulates. Paclitaxel, a major FDA-approved chemotherapeutic drug, was tested against HepG2 cells in order to compare the effectiveness of the Galaxy® matrices against traditional chemotherapy. In addition, a 24-hour bioassay was performed to compare the toxicity of Galaxy® each hour through the incubation period. Our results have shown that unfractionated Galaxy® has s.. Read More»
DOI:
10.4172/2327-5162.1000175
Alternative & Integrative Medicine received 476 citations as per Google Scholar report